Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orna Mor

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|December 26, 2016
Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groupsYosef Manor, Matthew Lewis, Daniela Ram, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 12, 2021
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation RecipientsYana Davidov, Keren Tsaraf, Oranit Cohen-Ezra, et al.
European Journal of Gastroenterology & Hepatology|March 3, 2021
The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionYana Davidov-Derevynko, Gil Ben Yakov, Anat Wieder, et al.
Viruses|May 25, 2024
The Outbreak of Unexplained Acute Hepatitis in Children: The Role of Viral Infections in View of the COVID-19 PandemicEyal Shteyer, Orna Mor, Orith Waisbourd-Zinman, et al.
Viruses|March 26, 2022
HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis BYael Gozlan, Daniella Aaron, Yana Davidov, et al.
Plos One|July 18, 2020
Advanced molecular surveillance approaches for characterization of blood borne hepatitis virusesMichael G Berg, Ana Olivo, Kenn Forberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1Itzchak Levy, Anat Wieder-Finesod, Vladyslav Litchevsky, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 19, 2022
Effective bubble-based testing for SARS-CoV-2 using swab-poolingYuval Cohen, Nadav Bamberger, Orna Mor, et al.
BMC Infectious Diseases|April 5, 2020
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trialLiat Deutsch, Inbal Houri, Ziv Ben-Ari, et al.
Journal of Hepatology|April 22, 2022
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipientsYana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|December 26, 2016
Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groupsYosef Manor, Matthew Lewis, Daniela Ram, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 12, 2021
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation RecipientsYana Davidov, Keren Tsaraf, Oranit Cohen-Ezra, et al.
European Journal of Gastroenterology & Hepatology|March 3, 2021
The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionYana Davidov-Derevynko, Gil Ben Yakov, Anat Wieder, et al.
Viruses|May 25, 2024
The Outbreak of Unexplained Acute Hepatitis in Children: The Role of Viral Infections in View of the COVID-19 PandemicEyal Shteyer, Orna Mor, Orith Waisbourd-Zinman, et al.
Viruses|March 26, 2022
HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis BYael Gozlan, Daniella Aaron, Yana Davidov, et al.
Plos One|July 18, 2020
Advanced molecular surveillance approaches for characterization of blood borne hepatitis virusesMichael G Berg, Ana Olivo, Kenn Forberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1Itzchak Levy, Anat Wieder-Finesod, Vladyslav Litchevsky, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 19, 2022
Effective bubble-based testing for SARS-CoV-2 using swab-poolingYuval Cohen, Nadav Bamberger, Orna Mor, et al.
BMC Infectious Diseases|April 5, 2020
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trialLiat Deutsch, Inbal Houri, Ziv Ben-Ari, et al.
Journal of Hepatology|April 22, 2022
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipientsYana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.
Pageof 10